Back

Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity

Medrano, R. F. V.; Sukhov, V.; Hoffer-Hawlik, K.; Rozenman, B.; Arthur, C. D.; Han, F.; Cheikh, B. B.; Sultan, H.; Takeuchi, Y.; Ameh, S.; Theisen, D. J.; Song, Y.; Kohlmiller, H. N.; White, J. M.; Sergushichev, A.; Zinselmeyer, B.; Leinert, P.; Leinert, W. P.; Sheehan, K. C. F.; Nolan, G.; Azizi, E.; Artyomov, M.; Schreiber, R. D.

2026-04-12 immunology
10.64898/2026.04.08.716779 bioRxiv
Show abstract

Spatially organized immune hubs of T cells and antigen-presenting cells (APCs) have been linked to immune checkpoint therapy (ICT) efficacy, yet the mechanisms underlying their function remain unclear. Using CODEX multiplex imaging, we longitudinally characterized the dynamic evolution of intratumoral cellular neighborhoods (CN) defined by "triad" interactions of CD4 and CD8 T cells with two distinct myeloid APC populations: cDC1s and IFN{gamma}-activated macrophages. We termed this CN the immunity-promoting CN (IP-CN) and tracked its progressive development during tumor rejection induced by -CTLA-4/-PD-1 therapy. A coordinated IFN{gamma} and TNF signaling signature accompanied the IP-CN assembly. Over time, the IP-CN underwent functional maturation, forming specialized sub-neighborhoods that compartmentalized proliferating T cells at the tumor periphery versus cytotoxic T effector cells interacting with tumor cell targets. Our findings reveal a spatiotemporal mechanism by which the IP-CN sustains and amplifies cytotoxic T cell responses, demonstrating how T cell-APC neighborhoods orchestrate tumor immunity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature
575 papers in training set
Top 1%
18.3%
2
Nature Immunology
71 papers in training set
Top 0.1%
9.9%
3
Cell
370 papers in training set
Top 1%
9.0%
4
Nature Communications
4913 papers in training set
Top 30%
6.3%
5
Cell Reports
1338 papers in training set
Top 10%
4.8%
6
Immunity
58 papers in training set
Top 1%
4.2%
50% of probability mass above
7
Advanced Science
249 papers in training set
Top 5%
3.9%
8
Science
429 papers in training set
Top 9%
3.5%
9
Cell Systems
167 papers in training set
Top 4%
3.0%
10
Science Advances
1098 papers in training set
Top 9%
2.8%
11
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 28%
2.0%
12
eLife
5422 papers in training set
Top 40%
1.8%
13
Nature Chemical Biology
104 papers in training set
Top 2%
1.5%
14
Journal of Experimental Medicine
106 papers in training set
Top 3%
1.3%
15
Nature Biotechnology
147 papers in training set
Top 5%
1.3%
16
Nature Nanotechnology
30 papers in training set
Top 0.8%
1.2%
17
Nature Medicine
117 papers in training set
Top 3%
1.2%
18
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
19
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
20
Cell Metabolism
49 papers in training set
Top 2%
0.9%
21
Cancer Discovery
61 papers in training set
Top 2%
0.9%
22
Cell Reports Medicine
140 papers in training set
Top 7%
0.9%
23
Science Immunology
81 papers in training set
Top 2%
0.9%
24
Nature Cell Biology
99 papers in training set
Top 4%
0.8%
25
Molecular Cell
308 papers in training set
Top 10%
0.8%
26
Nature Methods
336 papers in training set
Top 6%
0.7%
27
Nature Materials
21 papers in training set
Top 1%
0.7%
28
Nature Cancer
35 papers in training set
Top 1%
0.7%
29
Cell Stem Cell
57 papers in training set
Top 3%
0.6%
30
PLOS Biology
408 papers in training set
Top 23%
0.6%